One caveat is that this is necessarily a retrospective study. The authors looked at historical data from the UK Biobank, ran a regression, and found these genes. So, it’s not really clear if these genes are actually causing dementia, or if they’re just related to a common cause, or (most likely) tied together through some very complicated web of biological mechanisms.
That said, they’re interesting genes. GFAP is expressed in astrocytes, which are glial cells. These perform a lot of tasks in the brain, but they seem important in protecting neurons from toxic stresses. So, this may give us some additional insight into the role of glial cells like astrocytes in dementia.
> Proteins (for example Glial Fibrillary acidic protein, GFAP) had previously been identified as potential biomarkers for dementia in smaller studies, but this new research was much larger and conducted over several years.
The article (University press release) does mention this... but seeing a known suspect in the biomarker list would lend some confidence to any novel biomarkers found. So, it's good to see multiple studies having similar hits.
They mention this in the article, and of course, the scientific method means we _want_ to have more than one suggestive meta-analysis before we declare any kind of "discovery" at all.
> Proteins (for example Glial Fibrillary acidic protein, GFAP) had previously been identified as potential biomarkers for dementia in smaller studies, but this new research was much larger and conducted over several years.
"... plasma proteins, GFAP, NEFL, GDF15 and LTBP2 consistently associated most with incident all-cause dementia (ACD), Alzheimer’s disease (AD) and vascular dementia (VaD), and ranked high in protein importance ordering."
> Of 1,463 proteins analysed, aided by with a type of artificial intelligence known as machine learning, 11 proteins were identified and combined as a protein panel, which the researchers have shown to be highly accurate at predicting future dementia.
I understand that press releases are intended for non-technical folks but I don't get the point of this description. Is it assumed that machine learning is less understood than artificial intelligence?
It's always encouraging to see progress in disease prevention. As a young person, I'm looking forward to what the medical field will be like when I'm 70.
From what I understand, the medicine available is fairly successful at staving off further disease progression but the normal late stage diagnosis often means it’s far too late. This might make outcomes significantly better if it works as well as reported.
The article states there are medications that can slow or reverse the disease, if the disease is diagnosed early enough.
"An early diagnosis is critical for those with dementia. New drug technology can slow, or even reverse the progress of Alzheimer’s, but only if the disease is detected early enough. The drug lecanemab is one of two new treatments for the disease."
The most common but always impressive story I hear is that some dogs can smell cancer developing months or even a year before an official diagnosis. It honestly makes me wonder if the true next step for medical tooling should focus on enhancing human smell instead of sight to expand our spectrum or magnify microbes.
as another random trivia, many animals can often feel or hear an earthquake minutes to days in advance, demonstrated by unusual behavior. This is even less consistent but a phenomenon observed for millenia (wheras we didn't even properly name understand cancer until a few centuries at best).
bglazer|2 years ago
That said, they’re interesting genes. GFAP is expressed in astrocytes, which are glial cells. These perform a lot of tasks in the brain, but they seem important in protecting neurons from toxic stresses. So, this may give us some additional insight into the role of glial cells like astrocytes in dementia.
rwmj|2 years ago
Maxion|2 years ago
buyohmarkers|2 years ago
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177296/
mbreese|2 years ago
The article (University press release) does mention this... but seeing a known suspect in the biomarker list would lend some confidence to any novel biomarkers found. So, it's good to see multiple studies having similar hits.
rablackburn|2 years ago
> Proteins (for example Glial Fibrillary acidic protein, GFAP) had previously been identified as potential biomarkers for dementia in smaller studies, but this new research was much larger and conducted over several years.
elromulous|2 years ago
^ direct link to the paper.
ncr100|2 years ago
xkgt|2 years ago
I understand that press releases are intended for non-technical folks but I don't get the point of this description. Is it assumed that machine learning is less understood than artificial intelligence?
sr-latch|2 years ago
owenpalmer|2 years ago
unknown|2 years ago
[deleted]
ekianjo|2 years ago
m3kw9|2 years ago
berdon|2 years ago
stubish|2 years ago
"An early diagnosis is critical for those with dementia. New drug technology can slow, or even reverse the progress of Alzheimer’s, but only if the disease is detected early enough. The drug lecanemab is one of two new treatments for the disease."
hgomersall|2 years ago
quickthrower2|2 years ago
johnnyanmac|2 years ago
as another random trivia, many animals can often feel or hear an earthquake minutes to days in advance, demonstrated by unusual behavior. This is even less consistent but a phenomenon observed for millenia (wheras we didn't even properly name understand cancer until a few centuries at best).
unknown|2 years ago
[deleted]
loceng|2 years ago
foolfoolz|2 years ago
r-bryan|2 years ago
megamix|2 years ago
ransom1538|2 years ago
hanniabu|2 years ago